Sign In
Buy VCEL
$34.74
+0.290 (+0.84%)
At Close: Jun 03, 2026
Vericel - A Disruptive Business With Years Of Growth Remaining
11:34am, Tuesday, 12'th Apr 2022
Vericel is a high growth, disruptive medical technology company with average 5-year sales growth of 24%.
Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on March 22, 2022
08:30am, Tuesday, 15'th Mar 2022
CAMBRIDGE, Mass., March 15, 2022 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick C
Vericel to Present at the Cowen 42nd Annual Health Care Conference on March 9, 2022
08:30am, Tuesday, 01'st Mar 2022
CAMBRIDGE, Mass., March 01, 2022 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick C
Vericel (VCEL) Q4 2021 Earnings Call Transcript
11:30pm, Thursday, 24'th Feb 2022 The Motley Fool
VCEL earnings call for the period ending December 31, 2021.
Vericel Corporation (VCEL) CEO Nick Colangelo on Q4 2021 Results - Earnings Call Transcript
07:10pm, Thursday, 24'th Feb 2022 Seeking Alpha
Vericel Corporation 2021 Q4 - Results - Earnings Call Presentation
06:26pm, Thursday, 24'th Feb 2022 Seeking AlphaVericel Corporation (VCEL) CEO Nick Colangelo on Q4 2021 Results - Earnings Call Transcript
02:10pm, Thursday, 24'th Feb 2022
Vericel Corporation (VCEL) CEO Nick Colangelo on Q4 2021 Results - Earnings Call Transcript
Vericel GAAP EPS of $0.09 misses by $0.05, revenue of $47.6M misses by $0.49M; initiates FY22 guidance
12:58pm, Thursday, 24'th Feb 2022 Seeking Alpha
Vericel press release (VCEL): Q4 GAAP EPS of $0.09 misses by $0.05.Revenue of $47.6M (+5.3% Y/Y) misses by $0.49M.Gross margin of 72%, compared to 74% in the fourth quarter…
Vericel Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Full-Year 2022 Financial Guidance
12:55pm, Thursday, 24'th Feb 2022 GlobeNewswire
Full-Year 2021 Total Revenue Growth of 26%
Vericel Q4 2021 Earnings Preview
06:59pm, Wednesday, 23'rd Feb 2022 Seeking Alpha
Vericel (NASDAQ:VCEL) is scheduled to announce Q4 earnings results on Thursday, February 24th, before market open.The consensus EPS Estimate is $0.14 (-44.0% Y/Y) and the consensus…
Vericel (VCEL) Presents at the 40th Annual J.P. Morgan Healthcare Conference - Slideshow
12:04pm, Monday, 21'st Feb 2022 Seeking AlphaVericel to Report Fourth-Quarter 2021 Financial Results on February 24, 2022
02:00pm, Thursday, 10'th Feb 2022 GlobeNewswire
CAMBRIDGE, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the following webcast and conference call to discuss its fourth-quarter 2021 financial results and business highlights.
Vericel to Report Fourth-Quarter 2021 Financial Results on February 24, 2022
09:00am, Thursday, 10'th Feb 2022
CAMBRIDGE, Mass., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the followin
Vericel inks contract for new cell therapy manufacturing facility, headquarters
09:15pm, Wednesday, 02'nd Feb 2022 Seeking Alpha
Vericel Corporation (VCEL) entered into a long-term lease agreement for a new state-of-the-art advanced cell therapy manufacturing and corporate headquarters facility at the Network
Vericel trims 2021 guidance below expectations
03:04pm, Wednesday, 12'th Jan 2022 Seeking Alpha
Vericel Corporation <> is trading lower in morning hours after the company slashed its guidance for 2021 revenue growth to a range below the consensus.Ahead of its
